Nello Mainolfi

Chief Executive Officer, Director, Kymera Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$35.0M

Companies

Latest trade

Oct 1, 2026

Companies

Kymera Therapeutics, Inc.Chief Executive Officer, Director −$36.8M

Trades

KYMR Sold 30,000 shares at $113.80 · planned $3.4M Oct 1

KYMR Sold 50,000 shares at $119.00 · planned $6.0M Jul 7

KYMR Sold 80,000 shares at $115.30 · planned $9.2M Jul 1

KYMR Sold 30,000 shares at $81.18 · planned $2.4M Apr 29

KYMR Sold 30,000 shares at $90.26 · planned $2.7M Feb 25

KYMR Sold 30,000 shares at $78.06 · planned $2.3M Dec 31

KYMR Sold 100,000 shares at $89.17 · planned $8.9M Dec 8

KYMR Sold 30,000 shares at $60.99 · planned $1.8M Oct 29

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.